{
  "meta": {
    "title": "16_Cholesterol_Synthesis_Transport_And_Excretion",
    "url": "https://brainandscalpel.vercel.app/16-cholesterol-synthesis-transport-and-excretion-00520b56.html",
    "scrapedAt": "2025-11-30T12:26:36.911Z"
  },
  "questions": [
    {
      "text": "Where does cholesterol synthesis take place?",
      "choices": [
        {
          "id": 1,
          "text": "Cytosol and endoplasmic reticulum"
        },
        {
          "id": 2,
          "text": "Peroxisomes and mitochondria"
        },
        {
          "id": 3,
          "text": "Mitochondria and cytosol"
        },
        {
          "id": 4,
          "text": "Mitochondria and golgi body"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cholesterol synthesis</strong> takes place in the <strong>cytosol</strong> and <strong>endoplasmic reticulum</strong>.</p>\n<p><strong>Cytosolic acetyl-CoA</strong> forms <strong>acetoacetyl-CoA</strong>, which condenses with another acetyl-CoA to form <strong>HMG-CoA.</strong></p>\n<p>Cytosolic HMG-CoA, a key intermediate in cholesterol biosynthesis, is <strong>reduced</strong> in the <strong>endoplasmic reticulum</strong> to <strong>mevalonic acid</strong> by the <strong>regulatory enzyme HMG-CoA reductase</strong>. Mevalonic acid subsequently undergoes phosphorylation, decarboxylation , condensation and cyclicization reactions to produce cholesterol. </p>\n<p>Summary of cholesterol synthesis pathway: </p>\n<ul>\n<li aria-level=\"1\">Synthesis of <strong>mevalonate</strong> from <strong>acetyl-CoA</strong></li>\n<li aria-level=\"1\">Formation of<strong> isoprenoid units</strong> from mevalonate</li>\n<li aria-level=\"1\">Condensation of <strong>six</strong> isoprenoid units form <strong>squalene</strong></li>\n<li aria-level=\"1\">Cyclization of squalene to give rise to the parent steroid, <strong>lanosterol</strong></li>\n<li aria-level=\"1\">Formation of <strong>cholesterol</strong> from lanosterol.</li>\n</ul>\n<p>All tissues containing <strong>nucleated cells</strong> are capable of cholesterol synthesis, with the majority produced in the<strong> liver</strong> and <strong>intestine</strong>.</p><hr><h3>Related Pearl: Cholesterol synthesis</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/df36006c4ce64fe88295b170ef95d661x600x910.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9963",
      "difficulty": "medium"
    },
    {
      "text": "What is the substrate for cholesterol synthesis?",
      "choices": [
        {
          "id": 1,
          "text": "3-hydroxybutyrate"
        },
        {
          "id": 2,
          "text": "Acetoacetate"
        },
        {
          "id": 3,
          "text": "Acetyl CoA"
        },
        {
          "id": 4,
          "text": "Acyl  CoA"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cholesterol</strong> is<strong> synthesized</strong> from <strong>acetyl-CoA</strong> by a long pathway that may be divided into five steps</p>\n<ul>\n<li aria-level=\"1\">Synthesis of <strong>mevalonate</strong> from <strong>acetyl-CoA</strong></li>\n<li aria-level=\"1\">Formation of<strong> isoprenoid units</strong> from mevalonate</li>\n<li aria-level=\"1\">Condensation of <strong>six</strong> isoprenoid units form <strong>squalene</strong></li>\n<li aria-level=\"1\">Cyclization of squalene to give rise to the parent steroid, <strong>lanosterol</strong></li>\n<li aria-level=\"1\">Formation of <strong>cholesterol</strong> from lanosterol.</li>\n</ul>\n<p>All tissues containing <strong>nucleated cells</strong> are capable of cholesterol synthesis, with the majority produced in the<strong> liver</strong> and <strong>intestine</strong>.</p><hr><h3>Related Pearl: Cholesterol synthesis</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/df36006c4ce64fe88295b170ef95d661x600x910.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9964",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a primary bile acid?",
      "choices": [
        {
          "id": 1,
          "text": "Cholic acid"
        },
        {
          "id": 2,
          "text": "Chenodeoxycholic acid"
        },
        {
          "id": 3,
          "text": "Glycocholic acid"
        },
        {
          "id": 4,
          "text": "Deoxycholic acid"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Deoxycholic acid</strong> is not a primary bile acid. It is a <strong>secondary bile acid.</strong></p>\n<p>The <strong>primary bile acids</strong> are <strong>cholic acid</strong> and <strong>chenodeoxycholic acid</strong> synthesized from cholesterol in the liver. They are next conjugated with glycine and taurine in the <strong>liver peroxisomes</strong> to form glycocholic, glycochenodeoxycholic, taurocholic, and taurochenodeoxycholic acids.</p>\n<p>The <strong>secondary bile acids</strong> are formed in the intestine as the primary bile acids are <strong>deconjugated</strong> and <strong>dehydroxylated</strong> by the <strong>intestinal bacteria</strong> to form <strong>deoxycholic</strong> and<strong> lithocholic acid</strong>.</p>\n<p>These are absorbed in the<strong> ileum</strong> and returned to the liver by <strong>enterohepatic circulation</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9965",
      "difficulty": "medium"
    },
    {
      "text": "Which is the first intermediate in the conversion of cholesterol to bile acids?",
      "choices": [
        {
          "id": 1,
          "text": "7-dehydrocholesterol"
        },
        {
          "id": 2,
          "text": "7-hydroxycholesterol"
        },
        {
          "id": 3,
          "text": "Lanosterol"
        },
        {
          "id": 4,
          "text": "Ergosterol"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>first</strong> <strong>intermediate</strong> in the synthesis of bile acids is <strong>7α-hydroxycholesterol</strong></p>\n<p>This reaction is catalyzed by the <strong>enzyme 7α-hydroxylase</strong>, a microsomal CYP450 enzyme, which <strong>requires NADPH, oxygen, </strong>and<strong> vitamin C </strong>as co-factors. It is the <strong>rate-limiting step</strong> in the synthesis of bile acids.</p>\n<p><strong>Regulation of bile acid synthesis </strong>occurs by <strong>feedback inhibition of 7α-hydroxylase </strong>via the<strong> Farnesoid X receptor</strong>. When the level of bile acids in the enterohepatic circulation increases, FXR is activated and transcription of the enzyme is suppressed.</p>\n<p>Other options:</p>\n<p>Option A: 7-dehydrocholesterol is an intermediate in the conversion of cholesterol to vitamin D.</p>\n<p>Option C: Lanosterol is an intermediate in the synthesis of cholesterol.</p>\n<p>Option D: Ergosterol is a sterol found in plants.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9966",
      "difficulty": "medium"
    },
    {
      "text": "A 47-year-old diabetic man comes to the OPD for a follow-up visit. In the most recent lab report, serum LDL level is high. He is therefore started on a lipid-lowering drug that acts on the rate-limiting step of cholesterol synthesis. Which of the following is the site of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "HMG CoA synthase"
        },
        {
          "id": 2,
          "text": "HMG CoA reductase"
        },
        {
          "id": 3,
          "text": "Squalene epoxidase"
        },
        {
          "id": 4,
          "text": "HMG CoA lyase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>HMG-CoA reductase</strong> is the <strong>rate-limiting enzyme</strong> of cholesterol synthesis.</p>\n<p>HMG-CoA reductase is <strong>inhibited</strong> by the <strong>statin</strong> group of drugs (e.g. Atorvastatin, Rosuvastatin, Pravastatin, etc.), which are widely used as lipid-lowering agents.</p>\n<p>Regulation of HMG CoA reductase:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Activity increased by</strong></td>\n<td><strong>Activity decreased by</strong></td>\n</tr>\n<tr>\n<td>Insulin</td>\n<td>Glucagon, glucocorticoids</td>\n</tr>\n<tr>\n<td>Thyroid hormone</td>\n<td>Cholesterol, mevalonate</td>\n</tr>\n<tr>\n<td> </td>\n<td>Dietary cholesterol</td>\n</tr>\n<tr>\n<td> </td>\n<td>Statins</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Glucagon and glucocorticoids <strong>repress the transcription</strong> of HMG CoA reductase via sterol regulatory element-binding protein (SREBP).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2afac6c687004062b9e1b69d1334cbd3x600x566.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9967",
      "difficulty": "easy"
    },
    {
      "text": "Which is the first hormone to be produced in cholesterol synthesis?",
      "choices": [
        {
          "id": 1,
          "text": "Cholecystokinin"
        },
        {
          "id": 2,
          "text": "Epinephrin"
        },
        {
          "id": 3,
          "text": "Lanosterol"
        },
        {
          "id": 4,
          "text": "Secretin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Lanosterol</strong> is the <strong>first steroid</strong> to be synthesized <strong>in cholesterol synthesis</strong>.</p>\n<ul>\n<li>Cyclization of squalene gives rise to the parent steroid, lanosterol.</li>\n<li>The formation of cholesterol from lanosterol involves changes in the steroid nucleus and the side chain.</li>\n</ul><p>Note: Though lanosterol is technically not a hormone, it is the best choice among the listed options. This is a recent NEET question.</p><hr><h3>Related Pearl: Cholesterol synthesis</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/df36006c4ce64fe88295b170ef95d661x600x910.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9968",
      "difficulty": "easy"
    },
    {
      "text": "What is the function of lipoprotein?",
      "choices": [
        {
          "id": 1,
          "text": "Transport majority of nonpolar lipids"
        },
        {
          "id": 2,
          "text": "Transport majority of polar lipids"
        },
        {
          "id": 3,
          "text": "Transport only cholesterol"
        },
        {
          "id": 4,
          "text": "Transport only fatty acids"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Lipoproteins transport </strong>the<strong> </strong>majority of<strong> non-polar </strong><strong>lipids</strong> to most tissues for oxidation and to adipose tissue for storage as follows:</p>\n<ul>\n<li>From the intestines as <strong>chylomicrons</strong>, it carries <strong>exogenous</strong> triglycerides.</li>\n<li>From the liver as very-low-density lipoproteins (<strong>VLDL</strong>), it carries <strong>endogenous</strong> triglycerides.</li>\n</ul><hr><h3>Related Pearl: Distribution of  Various Apolipoproteins on Lipoproteins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons remnants</p>\n</td>\n<td>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IDL</p>\n</td>\n<td>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL</p>\n</td>\n<td>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HDL</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre- &beta;- HDL</p>\n</td>\n<td>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Familial Dyslipidemias</h3><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9969",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following lipoproteins have the highest cholesterol:triglyceride ratio?<div class='question-desc-html'><p>VLDL- Very low-density lipoprotein</p>\n<p>LDL- Low-density lipoprotein </p>\n<p>HDL- High-density lipoprotein </p>\n<p>IDL- Intermediate-density lipoprotein</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Chylomicron and VLDL"
        },
        {
          "id": 2,
          "text": "LDL and HDL"
        },
        {
          "id": 3,
          "text": "HDL and VLDL"
        },
        {
          "id": 4,
          "text": "IDL and HDL"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>As <strong>cholesterol</strong> is the predominant lipid in <strong>LDL</strong> and <strong>HDL</strong>, they have a <strong>higher cholesterol: triglyceride ratio.</strong></p>\n<p><strong>VLDL</strong> also has a significant amount of cholesterol but it <strong>predominantly comprises triglycerides</strong> (lower cholesterol: triglyceride ratio). Therefore <strong>LDL</strong> and <strong>HDL</strong> are considered the <strong>major carriers of cholesterol</strong>.</p>\n<p>IDLs are formed by the removal of triglycerides from VLDL by muscle and adipose tissue and are hence enriched in cholesterol. LDLs are derived from VLDL and IDL particles and contain more cholesterol than IDLs.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9970",
      "difficulty": "medium"
    },
    {
      "text": "In a patient with lipoprotein lipase deficiency, which of the following is increased following a fatty meal?",
      "choices": [
        {
          "id": 1,
          "text": "Chylomicron"
        },
        {
          "id": 2,
          "text": "LDL"
        },
        {
          "id": 3,
          "text": "HDL"
        },
        {
          "id": 4,
          "text": "Apo A"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>After a fatty meal, <strong>chylomicrons</strong> are elevated in<strong> lipoprotein lipase deficiency</strong>.</p>\n<p><strong>Chylomicrons</strong> transport dietary lipids from the intestine to the peripheral tissues. They are <strong>synthesized</strong> in the intestine by <strong>assembling apo B-48 with lipids</strong> (mainly triacylglycerols). This is called a nascent chylomicron, which upon receiving apo C-II and apo E from HDL is remodelled into mature chylomicron.</p>\n<p><strong>Apo C-II</strong> activates <strong>lipoprotein lipase</strong> present on the <strong>endothelium</strong>. Lipoprotein lipase hydrolyzes the triacylglycerols into fatty acids and glycerol which are either used for storage or energy. Therefore, patients who are <strong>deficient in lipoprotein lipase</strong> or <strong>apo C-II</strong> (<strong>type I hyperlipoproteinemia</strong>) show <strong>increased levels of chylomicrons</strong> in the plasma after a fatty meal.</p><hr><h3>Related Pearl: Familial Dyslipidemias</h3><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7422",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following lipoproteins are the major carriers of triacylglycerol?",
      "choices": [
        {
          "id": 1,
          "text": "Chylomicron and VLDL"
        },
        {
          "id": 2,
          "text": "LDL and HDL"
        },
        {
          "id": 3,
          "text": "HDL and VLDL"
        },
        {
          "id": 4,
          "text": "Chylomicron and HDL"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Triacylglycerol</strong> is predominantly carried by <strong>chylomicrons</strong> and <strong>VLDL.</strong></p><hr><h3>Related Pearl: Lipoprotein: Types, Sources and Action</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoproteins</strong></p>\n</td>\n<td>\n<p><strong>Source</strong></p>\n</td>\n<td>\n<p><strong>Action</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>Derived from intestinal absorption of triacylglycerol and other lipids</p>\n</td>\n<td>\n<p>Carry exogenous/dietary triacylglycerol from the intestine to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Very low density lipoproteins (VLDL)</p>\n</td>\n<td>\n<p>Derived from the liver</p>\n</td>\n<td>\n<p>Carry endogenous triacylglycerol from the liver to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low-density lipoproteins (LDL)</p>\n</td>\n<td>\n<p>Derived from VLDL</p>\n</td>\n<td>\n<p>Involved in cholesterol transport</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Highdensity lipoproteins (HDL)</p>\n</td>\n<td>\n<p>Derived from Liver, intestine, VLDL, chylomicrons</p>\n</td>\n<td>\n<p>Involved in reverse cholesterol &amp; Phospholipids transport and also in VLDL and chylomicron metabolism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Intermediate density lipoproteins(IDL)</p>\n</td>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>Triacylglycerol &amp; cholesterol transport</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9971",
      "difficulty": "easy"
    },
    {
      "text": "Which is the largest human plasma lipoprotein?",
      "choices": [
        {
          "id": 1,
          "text": "VLDL"
        },
        {
          "id": 2,
          "text": "LDL"
        },
        {
          "id": 3,
          "text": "HDL"
        },
        {
          "id": 4,
          "text": "Chylomicron"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Chylomicrons </strong>are the <strong>largest </strong>among<strong> plasma lipoproteins</strong>, which are especially <strong>rich</strong> in <strong>triacylglycerol.</strong></p><hr><h3>Related Pearl: Lipoprotein: Types, Sources and Action</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoproteins</strong></p>\n</td>\n<td>\n<p><strong>Source</strong></p>\n</td>\n<td>\n<p><strong>Action</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>Derived from intestinal absorption of triacylglycerol and other lipids</p>\n</td>\n<td>\n<p>Carry exogenous/dietary triacylglycerol from the intestine to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Very low density lipoproteins (VLDL)</p>\n</td>\n<td>\n<p>Derived from the liver</p>\n</td>\n<td>\n<p>Carry endogenous triacylglycerol from the liver to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low-density lipoproteins (LDL)</p>\n</td>\n<td>\n<p>Derived from VLDL</p>\n</td>\n<td>\n<p>Involved in cholesterol transport</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Highdensity lipoproteins (HDL)</p>\n</td>\n<td>\n<p>Derived from Liver, intestine, VLDL, chylomicrons</p>\n</td>\n<td>\n<p>Involved in reverse cholesterol &amp; Phospholipids transport and also in VLDL and chylomicron metabolism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Intermediate density lipoproteins(IDL)</p>\n</td>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>Triacylglycerol &amp; cholesterol transport</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9972",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements about HDL is false?",
      "choices": [
        {
          "id": 1,
          "text": "HDL act as  repository for the apo C and apo E."
        },
        {
          "id": 2,
          "text": "Class B scavenger receptor B1 (SRB-1) is HDL receptor."
        },
        {
          "id": 3,
          "text": "HDL removes cholesterol from tissues."
        },
        {
          "id": 4,
          "text": "HDL increases LDL oxidation."
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>HDL </strong>plays<strong> no role in LDL oxidation.</strong></p>\n<p>A major function of <strong>HDL</strong> is to<strong> act as a repository for </strong>the <strong>apo C and apo E</strong> required in the metabolism of chylomicrons and VLDL.</p>\n<p>The <strong>class B scavenger receptor B1 (SRB-1) </strong>has been identified as an <strong>HDL </strong>receptor with a dual role in HDL metabolism. SRB-1 mediates the <strong>acceptance</strong> of <strong>cholesterol</strong> <strong>effluxed</strong> from the cells <strong>by HDL</strong>, which then <strong>transports</strong> it to the liver <strong>for</strong> <strong>excretion</strong> via the bile.</p><hr><h3>Related Pearl: Lipoprotein: Types, Sources and Action</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoproteins</strong></p>\n</td>\n<td>\n<p><strong>Source</strong></p>\n</td>\n<td>\n<p><strong>Action</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>Derived from intestinal absorption of triacylglycerol and other lipids</p>\n</td>\n<td>\n<p>Carry exogenous/dietary triacylglycerol from the intestine to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Very low density lipoproteins (VLDL)</p>\n</td>\n<td>\n<p>Derived from the liver</p>\n</td>\n<td>\n<p>Carry endogenous triacylglycerol from the liver to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low-density lipoproteins (LDL)</p>\n</td>\n<td>\n<p>Derived from VLDL</p>\n</td>\n<td>\n<p>Involved in cholesterol transport</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Highdensity lipoproteins (HDL)</p>\n</td>\n<td>\n<p>Derived from Liver, intestine, VLDL, chylomicrons</p>\n</td>\n<td>\n<p>Involved in reverse cholesterol &amp; Phospholipids transport and also in VLDL and chylomicron metabolism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Intermediate density lipoproteins(IDL)</p>\n</td>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>Triacylglycerol &amp; cholesterol transport</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9974",
      "difficulty": "medium"
    },
    {
      "text": "An adolescent male with a history of recurrent abdominal pain and eruptive xanthoma is suspected to have a rare genetic condition affecting lipid metabolism. On serum lipid electrophoresis (diagram below)  band 1 (origin) is found to be wider than normal. <br><br>Activity of which of the following enzymes is reduced in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Lipoprotein Lipase"
        },
        {
          "id": 2,
          "text": "Hormone Sensitive Lipase"
        },
        {
          "id": 3,
          "text": "LCAT"
        },
        {
          "id": 4,
          "text": "HMG Co-A reductase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical vignette with a <strong>wide band</strong> at the <strong>origin</strong> on serum lipid electrophoresis is suggestive of <strong>familial hyperchylomicronemia</strong> (elevated chylomicron level in blood) which is associated with a <strong>deficiency of Lipoprotein Lipase</strong>. Familial Hyperchylomicronemia is also associated with <strong>hepatosplenomegaly</strong>, <strong>pancreatitis</strong> and <strong>eruptive/pruritic xanthoma</strong>. Serum biochemistry commonly reveals increased chylomicron, triglyceride and cholesterol levels in the blood.</p>\n<p><strong>Chylomicron</strong> has the <strong>lowest mobility</strong> on serum lipid electrophoresis and the chylomicron band appears at the origin location (initial location). On the other hand, <strong>HDL</strong> has the <strong>highest electrophoretic mobility</strong> and the least lipid content.</p>\n<p>As a general rule, lipoproteins with <strong>higher protein</strong> content will move <strong>faster towards</strong> the <strong>anode</strong> and those with <strong>fewer proteins</strong> have <strong>minimal mobility.</strong> </p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td>Chylomicron</td>\n<td>VLDL</td>\n<td>IDL</td>\n<td>LDL</td>\n<td>HDL</td>\n</tr>\n<tr>\n<td>Electrophoretic mobility</td>\n<td>origin</td>\n<td>pre-beta</td>\n<td>broad-beta</td>\n<td>beta</td>\n<td>alpha</td>\n</tr>\n<tr>\n<td>Protein composition (%)</td>\n<td>2</td>\n<td>10</td>\n<td>20</td>\n<td>20</td>\n<td>30-60</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6795fef8384f418ca39511de16863756x1280x1190.JPEG\" alt=\"Explanation Image\"><p>Note: Even though <strong>VLDL</strong> has a lesser percentage of proteins with respect to LDL, it <strong>moves ahead of LDL closer to the anode </strong>due to the presence of <strong>more net negative charge in VLDL</strong></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a275cd98f84c45b79d02a878aaf2f393.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9975",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following contains apolipoprotein A?<div class='question-desc-html'><ol>\n<li>Chylomicron</li>\n<li>HDL</li>\n<li>LDL</li>\n<li>IDL</li>\n<li>VLDL</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1,2,3"
        },
        {
          "id": 2,
          "text": "1,2"
        },
        {
          "id": 3,
          "text": "3,5"
        },
        {
          "id": 4,
          "text": "2,4,5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Apolipoprotein A</strong> is found in <strong>chylomicron</strong> and <strong>HDL</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td rowspan=\"2\">Lipoproteins</td>\n<td colspan=\"4\">Corresponding Apolipoproteins</td>\n</tr>\n<tr>\n<td>Apo-</td>\n<td>Apo-</td>\n<td>Apo-</td>\n<td>Apo-</td>\n</tr>\n<tr>\n<td>HDL</td>\n<td><strong>A</strong></td>\n<td><strong>C</strong></td>\n<td><strong>E</strong></td>\n<td><strong>D</strong></td>\n</tr>\n<tr>\n<td>Chylomicron</td>\n<td><strong>A</strong></td>\n<td><strong>C</strong></td>\n<td><strong>E</strong></td>\n<td><strong>B<sub>48</sub></strong></td>\n</tr>\n<tr>\n<td>VLDL</td>\n<td>&nbsp;</td>\n<td><strong>C</strong></td>\n<td><strong>E</strong></td>\n<td><strong>B<sub>100</sub></strong></td>\n</tr>\n<tr>\n<td>IDL</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td><strong>E</strong></td>\n<td><strong>B<sub>100</sub></strong></td>\n</tr>\n<tr>\n<td>LDL</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td><strong>B<sub>100</sub></strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Distribution of  Various Apolipoproteins on Lipoproteins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons remnants</p>\n</td>\n<td>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IDL</p>\n</td>\n<td>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL</p>\n</td>\n<td>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HDL</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre- &beta;- HDL</p>\n</td>\n<td>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9977",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following has the highest electrophoretic mobility and least lipid content?",
      "choices": [
        {
          "id": 1,
          "text": "Chylomicrons"
        },
        {
          "id": 2,
          "text": "HDL"
        },
        {
          "id": 3,
          "text": "LDL"
        },
        {
          "id": 4,
          "text": "VLDL"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>HDL</strong> has the <strong>highest</strong> <strong>electrophoretic</strong> <strong>mobility</strong> and the <strong>least lipid</strong> content. HDL particles are the densest.</p>\n<p>On electrophoresis, HDL moves farthest on the electrophoretic plate towards the anode. On the other hand, the <strong>chylomicron does not move</strong> towards the charged end in electrophoresis, thus having the lowest mobility. As a general rule,<strong> lipoproteins</strong> with <strong>higher protein</strong> content will <strong>move faster</strong> towards the <strong>anode</strong> and those with fewer proteins have minimal mobility.</p>\n<p>The density of various lipoproteins and their electrophoretic mobility are shown in the images below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2076687af52640e28cd52733b51efb77x1280x1190.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9987",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the main apolipoprotein present in LDL ?",
      "choices": [
        {
          "id": 1,
          "text": "Apo B-100"
        },
        {
          "id": 2,
          "text": "Apo E"
        },
        {
          "id": 3,
          "text": "Apo-48"
        },
        {
          "id": 4,
          "text": "Apo A-11"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The main apolipoprotein of <strong>LDL</strong> (&beta;-lipoprotein) is <strong>apo B(B-100),</strong> which is found also in VLDL.</p>\n<table>\n<tbody>\n<tr>\n<td rowspan=\"2\">&nbsp;Lipoproteins</td>\n<td colspan=\"4\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corresponding Apolipoproteins</td>\n</tr>\n<tr>\n<td>Apo-</td>\n<td>Apo-</td>\n<td>Apo-</td>\n<td>Apo-</td>\n</tr>\n<tr>\n<td>HDL</td>\n<td><strong>A</strong></td>\n<td><strong>C</strong></td>\n<td><strong>E</strong></td>\n<td><strong>D</strong></td>\n</tr>\n<tr>\n<td>Chylomicron</td>\n<td><strong>A</strong></td>\n<td><strong>C</strong></td>\n<td><strong>E</strong></td>\n<td><strong>B<sub>48</sub></strong></td>\n</tr>\n<tr>\n<td>VLDL</td>\n<td>&nbsp;</td>\n<td><strong>C</strong></td>\n<td><strong>E</strong></td>\n<td><strong>B<sub>100</sub></strong></td>\n</tr>\n<tr>\n<td>IDL</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td><strong>E</strong></td>\n<td><strong>B<sub>100</sub></strong></td>\n</tr>\n<tr>\n<td>LDL</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td><strong>B<sub>100</sub></strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Distribution of  Various Apolipoproteins on Lipoproteins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons remnants</p>\n</td>\n<td>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IDL</p>\n</td>\n<td>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL</p>\n</td>\n<td>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HDL</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre- &beta;- HDL</p>\n</td>\n<td>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9980",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements about LDL is false?",
      "choices": [
        {
          "id": 1,
          "text": "It delivers cholesterol to cells."
        },
        {
          "id": 2,
          "text": "It contains only one apoprotein."
        },
        {
          "id": 3,
          "text": "It is the marker of cardiovascular disease."
        },
        {
          "id": 4,
          "text": "It contains Apo B-48."
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Apo B-48</strong> is <strong>not</strong> the <strong>ligand of LDL.</strong></p>\n<p><strong>Apo B-48</strong> is the apolipoprotein present on <strong>nascent chylomicrons</strong>. The main apolipoprotein of <strong>LDL</strong> (β-lipoprotein) is <strong>apo B(B-100),</strong> which is found also in VLDL.</p>\n<p>Low-density lipoproteins (<strong>LDL</strong>) <strong>deliver</strong> <strong>cholesterol</strong> <strong>to</strong> the <strong>tissues, </strong>hence it is a <strong>marker of cardiovascular disease</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td rowspan=\"2\"> Lipoproteins</td>\n<td colspan=\"4\">                       Corresponding Apolipoproteins</td>\n</tr>\n<tr>\n<td>Apo-</td>\n<td>Apo-</td>\n<td>Apo-</td>\n<td>Apo-</td>\n</tr>\n<tr>\n<td>HDL</td>\n<td><strong>A</strong></td>\n<td><strong>C</strong></td>\n<td><strong>E</strong></td>\n<td><strong>D</strong></td>\n</tr>\n<tr>\n<td>Chylomicron</td>\n<td><strong>A</strong></td>\n<td><strong>C</strong></td>\n<td><strong>E</strong></td>\n<td><strong>B<sub>48</sub></strong></td>\n</tr>\n<tr>\n<td>VLDL</td>\n<td> </td>\n<td><strong>C</strong></td>\n<td><strong>E</strong></td>\n<td><strong>B<sub>100</sub></strong></td>\n</tr>\n<tr>\n<td>IDL</td>\n<td> </td>\n<td> </td>\n<td><strong>E</strong></td>\n<td><strong>B<sub>100</sub></strong></td>\n</tr>\n<tr>\n<td>LDL</td>\n<td> </td>\n<td> </td>\n<td> </td>\n<td><strong>B<sub>100</sub></strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Distribution of  Various Apolipoproteins on Lipoproteins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons remnants</p>\n</td>\n<td>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IDL</p>\n</td>\n<td>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL</p>\n</td>\n<td>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HDL</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre- &beta;- HDL</p>\n</td>\n<td>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9982",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is an activator of the key enzyme required in reverse cholesterol transport?",
      "choices": [
        {
          "id": 1,
          "text": "Apo B-100"
        },
        {
          "id": 2,
          "text": "Apo B-48"
        },
        {
          "id": 3,
          "text": "Apo A-IV"
        },
        {
          "id": 4,
          "text": "Apo A-I"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Apo A-I</strong> is the <strong>activator</strong> of <strong>Lecithin: cholesterol acyltransferase (LCAT)</strong>, the enzyme present in <strong>HDL</strong> facilitating <strong>reverse cholesterol transport.</strong></p>\n<p>Lecithin-cholesterol acyltransferase (LCAT) is activated by apo A-I which then converts <strong>free cholesterol(amphipathic)</strong> in HDL to <strong>cholesterol ester(hydrophobic)</strong>. As a result the initial discoidal shape now becomes spherical.</p>\n<p>This facilitates <strong>reverse cholesterol transport.</strong></p>\n<p>Clinical correlation: <strong>Familial LCAT deficiency</strong> will lead to failure of reverse cholesterol transport resulting in <strong>cholesterol deposition</strong> in specific <strong>peripheral tissues </strong>- the<strong> cornea, kidneys, </strong>and <strong>erythrocytes</strong>. Major complications include <strong>premature atherosclerosis, </strong>renal failure, anemia and corneal opacities<strong>.</strong> HDL cholesterol level is decreased.</p><hr><h3>Related Pearl: Distribution of  Various Apolipoproteins on Lipoproteins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons remnants</p>\n</td>\n<td>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IDL</p>\n</td>\n<td>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL</p>\n</td>\n<td>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HDL</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre- &beta;- HDL</p>\n</td>\n<td>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9983",
      "difficulty": "medium"
    },
    {
      "text": "Which apoprotein do chylomicrons require in order to enter the lymph?",
      "choices": [
        {
          "id": 1,
          "text": "Apo B-48"
        },
        {
          "id": 2,
          "text": "Apo B-100"
        },
        {
          "id": 3,
          "text": "Apo C"
        },
        {
          "id": 4,
          "text": "Apo E"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Each nascent <strong>chylomicron</strong> particle has one molecule of <strong>apolipoprotein(apo) B-48 </strong>with which chylomicrons are released from the cells <strong>into</strong> the <strong>lymphatic system</strong> and travel to the blood, where they receive apo C-II and apo E from HDLs.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9984",
      "difficulty": "medium"
    },
    {
      "text": "Where does IDL become LDL?",
      "choices": [
        {
          "id": 1,
          "text": "Blood capillaries of the liver"
        },
        {
          "id": 2,
          "text": "Cytosol of liver"
        },
        {
          "id": 3,
          "text": "Heart"
        },
        {
          "id": 4,
          "text": "Mitochondria of liver"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>IDL </strong>(Intermediate-density lipoprotein) particles are rapidly taken up by the <strong>liver</strong> in <strong>circulation</strong>, where they undergo further triglyceride hydrolysis and are <strong>converted to LDL (Low density lipoprotein)</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9985",
      "difficulty": "medium"
    },
    {
      "text": "A 56-year-old man suffering from uncontrolled diabetes mellitus came for a routine checkup. His lipid profile revealed increased TG (triacylglycerol) and VLDL (very low-density lipoprotein). What is the cause of this abnormal lipid profile?",
      "choices": [
        {
          "id": 1,
          "text": "Increased activity of lipoprotein lipase and decreased activity of hormone sensitive lipase"
        },
        {
          "id": 2,
          "text": "Increased activity of hormone sensitive lipase and decreased lipoprotein lipase activity"
        },
        {
          "id": 3,
          "text": "Increase in peripheral function of LDL receptors"
        },
        {
          "id": 4,
          "text": "Increased in activity of hepatic lipase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In chronic diabetes, the values of TG and VLDL are increased due to an <strong>increase </strong>in<strong> hormone-sensitive lipase </strong>and a<strong> decrease</strong> in <strong>lipoprotein lipase.</strong></p>\n<p>Insulin has an <strong>inhibitory effect</strong> on hormone-sensitive lipase (HSL). In diabetes, <strong>low insulin</strong> corresponds to an increase in HSL activity. This promotes the <strong>breakdown</strong> of <strong>lipids </strong>and the <strong>release</strong> of <strong>TG</strong> and free fatty acids from the adipose tissue.</p>\n<p>Insulin induces the activity of lipoprotein lipase (LPL) which is present on the capillary walls. LPL promotes hydrolysis of TG and the degradation of the transport proteins, VLDL, and chylomicrons. In diabetes, <strong>low insulin</strong> leads to <strong>decreased LPL</strong> activity which corresponds to an <strong>increase</strong> in <strong>VLDL</strong> and <strong>TG.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/930c5ce53b9a48df908e15bf24113255x800x552.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Hormone sensitive lipase  Vs lipoprotein lipase</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;HSL</td>\n<td>&nbsp;Lipoprotein lipase</td>\n</tr>\n<tr>\n<td>Location</td>\n<td>&nbsp;Adipocyte</td>\n<td>&nbsp;Capillaries</td>\n</tr>\n<tr>\n<td>Action</td>\n<td>&nbsp;Hydrolyse TAG in adipose&nbsp; &nbsp;tissue</td>\n<td>&nbsp;Hydrolyse TAG in chylomicron , VLDL</td>\n</tr>\n<tr>\n<td>Acts in the state of</td>\n<td>&nbsp;Fasting (Glucagon)</td>\n<td>&nbsp;Fed (Insulin)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD1280",
      "difficulty": "medium"
    }
  ]
}